Lobby organisation
BeOne Medicines I GmbH
Business / industry · Health & pharma · HQ: Switzerland · Transparency Register entry
As of 9 September 2026, BeOne Medicines I GmbH appears in 4 declared MEP meetings (4 different MEPs), most often with European People's Party.
In their own words
“BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team of nearly 12,000…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 4 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2026–2026. Bar length is relative to its busiest year (4 in 2026). All meetings were in one calendar year.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 4 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 6 May 2026 | Oliver Schenk | oncology innovation and EU cancer policy |
| 16 Apr 2026 | Sophie Wilmès | Cancer |
| 15 Apr 2026 | Michalis Hadjipantela | Introductory meeting |
| 31 Mar 2026 | Vytenis Povilas Andriukaitis | Biotech Act |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.